Eli Lilly will buy Boston‑based Centessa for about $6.3B, adding an orexin agonist program led by cleminorexton. The deal pays $38 per ADS up front and could reach $47 with milestones.

A $280 million renewal from the Stanley Family Foundation brings its Broad Institute giving past $1 billion and backs genetics and translational work on bipolar and schizophrenia.

Biogen agreed to buy Apellis for about $5.6B, paying $41 a share to add pegcetacoplan programs and expand into rare kidney disease treatments.

Fenway-based Whoop raised $575M at roughly a $10B valuation, fueling a 600-job expansion and renewed IPO talk. The funding brings strategic investors and new runway.

Waltham‑based Kailera Therapeutics filed for an IPO on March 30, 2026 after raising nearly $1 billion and advancing an oral and injectable GLP‑1 obesity pipeline.

A federal patent board sided with the Broad Institute on March 27, 2026, preserving key U.S. CRISPR patents and complicating licensing and appeals.

Clasp raised $20 million and will double its Boston staff to scale an employer-sponsored loan-repayment hiring model. The round backs a hiring push across product and partnerships.

Mayor Michelle Wu will unveil a public‑private partnership at Eliot Upper School aimed at making Boston Public Schools a national leader in K‑12 AI literacy. The plan emphasizes classroom curriculum, teacher training and private‑sector support.

Cambridge Mobile Telematics raised $350M from TPG, Allianz and State Farm to expand in Europe and scale AI crash-detection while adding engineering roles in Cambridge.

Pfizer and Valneva say their VLA15 Lyme vaccine is showing promise in late‑stage trials; a Phase 3 readout is expected in early 2026.

Quotient Therapeutics, a Flagship spinout in Cambridge, struck a potential $2.2B partnership with Merck to mine somatic genomes for inflammatory bowel disease targets.

Abbott has closed its roughly $21B purchase of Exact Sciences, paying $105 a share and folding Cologuard and other cancer‑testing assets into its diagnostics arm while keeping Exact’s Madison operations intact.

An international drilling mission found low‑salinity water trapped beneath the Atlantic off New England. Early estimates say the supply could be huge — but tapping it would be complex.